TAS-102 in Combination With Regorafenib or Fruquintinib for Third-line and Above Advanced Colorectal Cancer
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
This is a single-arm, multicentre real-world observational study of TAS-102 in combination with regorafenib or fruquintinib for third-line and above advanced colorectal cancer.
创建时间：
2023-09-15
